{"pmid":32266937,"title":"Inside the heart of COVID-19.","text":["Inside the heart of COVID-19.","Cardiovasc Res","Adao, Rui","32266937"],"journal":"Cardiovasc Res","authors":["Adao, Rui"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266937","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cvr/cvaa086","keywords":["Cardiovascular system","Coronavirus Pandemic Angiotensin-converting enzyme 2","SARS-CoV-2"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663609715789135873,"score":7.9164424,"similar":[{"pmid":32252591,"title":"COVID-19 and the Heart.","text":["COVID-19 and the Heart.","Infection with the novel coronavirus, SARS-CoV-2, produces a clinical syndrome known as COVID-19. When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm and elevations of cardiac injury biomarkers. Here we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020.","Circ Res","Akhmerov, Akbarshakh","Marban, Eduardo","32252591"],"abstract":["Infection with the novel coronavirus, SARS-CoV-2, produces a clinical syndrome known as COVID-19. When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm and elevations of cardiac injury biomarkers. Here we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020."],"journal":"Circ Res","authors":["Akhmerov, Akbarshakh","Marban, Eduardo"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32252591","week":"202015|Apr 06 - Apr 12","doi":"10.1161/CIRCRESAHA.120.317055","keywords":["cell therapy","coronavirus","cytokine storm"],"source":"PubMed","topics":["Diagnosis","Treatment","Mechanism"],"weight":1,"_version_":1663450393421545472,"score":52.766293},{"pmid":32227090,"title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.","text":["The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.","A new type of pneumonia caused by a novel coronavirus SARS-CoV-2 outbreaks recently in China and spreads into many other countries. This disease, named as COVID-19, is similar to patients infected by SARS-CoV and MERS-CoV, and nearly 20% of patients developed severe condition. Cardiac injury is a prevalent complication of severe patients, exacerbating the disease severity in coronavirus disease 2019 (COVID-19) patients. Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SARS-CoV-2, has been identified in multiple organs, but its cellular distribution in human heart is not illuminated clearly. This study performed the first state-of-art single cell atlas of adult human heart, and revealed that pericytes with high expression of ACE2 might act as the target cardiac cell of SARS-CoV-2. The pericytes injury due to virus infection may result in capillary endothelial cells dysfunction, inducing microvascular dysfunction. And patients with basic heart failure disease showed increased ACE2 expression at both mRNA and protein levels, meaning that if infected by the virus these patients may have higher risk of heart attack and critically ill condition. The finding of this study explains the high rate of severe cases among COVID-19 patients with basic cardiovascular disease; and these results also perhaps provide important reference to clinical treatment of cardiac injury among severe patients infected by SARS-CoV-2.","Cardiovasc Res","Chen, Liang","Li, Xiangjie","Chen, Mingquan","Feng, Yi","Xiong, Chenglong","32227090"],"abstract":["A new type of pneumonia caused by a novel coronavirus SARS-CoV-2 outbreaks recently in China and spreads into many other countries. This disease, named as COVID-19, is similar to patients infected by SARS-CoV and MERS-CoV, and nearly 20% of patients developed severe condition. Cardiac injury is a prevalent complication of severe patients, exacerbating the disease severity in coronavirus disease 2019 (COVID-19) patients. Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SARS-CoV-2, has been identified in multiple organs, but its cellular distribution in human heart is not illuminated clearly. This study performed the first state-of-art single cell atlas of adult human heart, and revealed that pericytes with high expression of ACE2 might act as the target cardiac cell of SARS-CoV-2. The pericytes injury due to virus infection may result in capillary endothelial cells dysfunction, inducing microvascular dysfunction. And patients with basic heart failure disease showed increased ACE2 expression at both mRNA and protein levels, meaning that if infected by the virus these patients may have higher risk of heart attack and critically ill condition. The finding of this study explains the high rate of severe cases among COVID-19 patients with basic cardiovascular disease; and these results also perhaps provide important reference to clinical treatment of cardiac injury among severe patients infected by SARS-CoV-2."],"journal":"Cardiovasc Res","authors":["Chen, Liang","Li, Xiangjie","Chen, Mingquan","Feng, Yi","Xiong, Chenglong"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227090","week":"202014|Mar 30 - Apr 05","doi":"10.1093/cvr/cvaa078","keywords":["ACE2","Heart failure","Heart injury","SARS-CoV-2"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352135243268096,"score":51.572403},{"pmid":32220710,"pmcid":"PMC7118521","title":"Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2.","text":["Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2.","Med Hypotheses","Roncati, Luca","Gallo, Graziana","Manenti, Antonio","Palmieri, Beniamino","32220710"],"journal":"Med Hypotheses","authors":["Roncati, Luca","Gallo, Graziana","Manenti, Antonio","Palmieri, Beniamino"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32220710","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.mehy.2020.109686","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352135177207808,"score":49.70274},{"pmid":32274570,"title":"COVID-19 in the heart and the lungs: could we \"Notch\" the inflammatory storm?","text":["COVID-19 in the heart and the lungs: could we \"Notch\" the inflammatory storm?","From January 2020, coronavirus disease (COVID-19) originated in China has spread around the world. The disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The presence of myocarditis, cardiac arrest, and acute heart failure in COVID-19 patients suggests the existence of a relationship between SARS-CoV-2 infection and cardiac disease. The Notch signalling is a major regulator of cardiovascular function and it is also implicated in several biological processes mediating viral infections. In this report we discuss the possibility to target Notch signalling to prevent SARS-CoV-2 infection and interfere with the progression of COVID-19- associated heart and lungs disease.","Basic Res Cardiol","Rizzo, Paola","Vieceli Dalla Sega, Francesco","Fortini, Francesca","Marracino, Luisa","Rapezzi, Claudio","Ferrari, Roberto","32274570"],"abstract":["From January 2020, coronavirus disease (COVID-19) originated in China has spread around the world. The disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The presence of myocarditis, cardiac arrest, and acute heart failure in COVID-19 patients suggests the existence of a relationship between SARS-CoV-2 infection and cardiac disease. The Notch signalling is a major regulator of cardiovascular function and it is also implicated in several biological processes mediating viral infections. In this report we discuss the possibility to target Notch signalling to prevent SARS-CoV-2 infection and interfere with the progression of COVID-19- associated heart and lungs disease."],"journal":"Basic Res Cardiol","authors":["Rizzo, Paola","Vieceli Dalla Sega, Francesco","Fortini, Francesca","Marracino, Luisa","Rapezzi, Claudio","Ferrari, Roberto"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32274570","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s00395-020-0791-5","keywords":["ADAM17","Angiotensin-converting enzyme 2","COVID-19","Cardiovascular disease","Coronavirus disease","Furin","Notch"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663712077829636097,"score":45.641808},{"pmid":32267000,"title":"Patterns of heart Injury in COVID - 19 and relation to outcome.","text":["Patterns of heart Injury in COVID - 19 and relation to outcome.","We read with much interest the article \"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China\" by Han et al as published in March 2020. In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT- proBNP on the outcome of 273 patients with COVID-19 disease. This article is protected by copyright. All rights reserved.","J Med Virol","Mishra, Ajay Kumar","Sahu, Kamal Kant","Lal, Amos","Sargent, Jennifer","32267000"],"abstract":["We read with much interest the article \"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China\" by Han et al as published in March 2020. In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT- proBNP on the outcome of 273 patients with COVID-19 disease. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Mishra, Ajay Kumar","Sahu, Kamal Kant","Lal, Amos","Sargent, Jennifer"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267000","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25847","source":"PubMed","topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1663609715800670208,"score":44.3214}]}